Cardascia Nicola, Palmisano Carmela, Centoducati Tersa, Alessio Giovanni
Dipartimento di Scienze Mediche di Base, Neuroscienze ed Organi di Senso. Sezione di Oftalmologia, Università degli Studi di Bari Aldo Moro, Bari, Italy.
RUO Oftalmologia, Policlinico Consorziale di Bari, p.zza G. Cesare, 11, 70124, Bari, Italy.
Int Ophthalmol. 2017 Oct;37(5):1127-1131. doi: 10.1007/s10792-016-0374-5. Epub 2016 Oct 20.
The purpose of the study was to assess adjuvant treatment with topical nonsteroidal anti-inflammatory drugs (NSAIDs) (0.9 % bromfenac, 0.1 % nepafenac, 0.5 % indomethacin, or 0.1 % diclofenac) in addition to topical steroidal treatment with 0.1 % dexamethasone and 0.3 % netilmicin for prevention of cystoid macular edema (CME) after uneventful small incision cataract extraction with foldable intraocular lens (IOL) implantation.
Institute of Ophthalmology, Department of Scienze Mediche di Base, Neuroscienze ed Organi di Senso, Aldo Moro University, Policlinico Consorziale di Bari, Bari, Italy.
A retrospective 6-month single center study.
Patients were divided into groups according to treatment with topical drugs for 2 weeks, after phacoemulsification with foldable IOL implantation. CME incidence was evaluated by assessing retinal foveal thickness changes using spectral domain optical coherence tomography. All patients were treated with a fixed combination of dexamethasone and netilmicin, and some patients were additionally treated with NSAIDs (bromfenac, nepafenac, indomethacin, or diclofenac).
Fourteen patients were treated with bromfenac, 15 with nepafenac, 12 with indomethacin, and 14 with diclofenac; ten patients were treated with dexamethasone and netilmicin alone. At the end of the follow-up, macular thickness, evaluated at 1-week post-surgery, was reduced only in the group treated with nepafenac (-1.3 %, p = 0.048), was increased in the group treated with dexamethasone and netilmicin alone (+4.3 %, p = 0.04), and did not change in the groups treated with bromfenac (-1.1 %, p = 0.3), indomethacin (+0.1 %, p = 0.19), or diclofenac (+1.2 %, p = 0.74). There were no side effects in any group.
Topical treatment with nepafenac, bromfenac, and indomethacin enhanced the efficacy of steroids to reduce postoperative macular edema. Diclofenac did not improve steroids efficacy.
本研究旨在评估在使用0.1%地塞米松和0.3%奈替米星进行局部类固醇治疗的基础上,联合使用局部非甾体抗炎药(NSAIDs)(0.9%溴芬酸、0.1%奈帕芬酸、0.5%吲哚美辛或0.1%双氯芬酸)预防在顺利进行小切口白内障摘除并植入可折叠人工晶状体(IOL)后发生的黄斑囊样水肿(CME)。
意大利巴里市巴里奥尔多·莫罗大学基础医学、神经科学与感觉器官科学系眼科研究所。
一项为期6个月的回顾性单中心研究。
在进行超声乳化并植入可折叠IOL后,根据局部用药治疗2周将患者分组。通过使用光谱域光学相干断层扫描评估视网膜中央凹厚度变化来评估CME发病率。所有患者均接受地塞米松和奈替米星的固定联合治疗,部分患者还额外接受了NSAIDs(溴芬酸、奈帕芬酸、吲哚美辛或双氯芬酸)治疗。
14例患者接受溴芬酸治疗,15例接受奈帕芬酸治疗,12例接受吲哚美辛治疗,14例接受双氯芬酸治疗;10例患者仅接受地塞米松和奈替米星治疗。随访结束时,术后1周评估的黄斑厚度仅在接受奈帕芬酸治疗的组中降低(-1.3%,p = 0.048),在仅接受地塞米松和奈替米星治疗的组中增加(+4.3%,p = 0.04),而在接受溴芬酸治疗的组中无变化(-1.1%,p = 0.3),接受吲哚美辛治疗的组中无变化(+0.1%,p = 0.19),接受双氯芬酸治疗的组中无变化(+1.2%,p = 0.74)。任何组均未出现副作用。
局部使用奈帕芬酸、溴芬酸和吲哚美辛可增强类固醇减少术后黄斑水肿的疗效。双氯芬酸未改善类固醇的疗效。